Skip to main content
. Author manuscript; available in PMC: 2023 Jan 10.
Published in final edited form as: Lancet Healthy Longev. 2022 Nov 18;3(12):e817–e824. doi: 10.1016/S2666-7568(22)00241-0

Table 3:

Comparison of prospective studies meeting 2017 and 2020 Lancet Commission inclusion criteria examining associations with pure-tone threshold and development of dementia6,7

Cohort size, N Incident dementia, n Mean age, years Method of hearing testing Median or mean follow-up, years Adjusted HR or OR (95% CI)*

Lin et al (2011)11   639 58 64 Automated audiometer in sound-attenuating booth 12 1·27 (1·06–1·50)
Gallacher et al (2012)13 1057 79 56 Behavioural audiometry in community clinic with background noise 17 2·67 (1·38–5·18)
Deal et al (2017)12 1889 229 76 Behavioural audiometry in sound-attenuating booth 9 1·14 (1·03–1·26)
Current study 1200 207 76 Comprehensive behavioural audiometry with audiologist in sound-attenuating booth 7 0·99 (0·89–1·12)

HR=hazard ratio. OR=odds ratio.

*

The study by Gallacher et al reported an OR to assess the odds of having hearing loss and dementia; the remaining studies listed in the table reported HRs. All HRs or ORs represent the association of a 10 decibels hearing level increase in PTA with development of dementia. All HRs or ORs were adjusted for age but studies differed in the number of additional adjusting features.

The study by Lin et al did not directly report mean age for the entire cohort; the summary included in this table was derived from published mean ages for the subsets of the 639 patients with and without dementia. Moreover, the reported follow-up of 12 years represents a median, not a mean.